Live
FierceBiotechRoche sticks with €600M diagnostics investment in Germany but warns of future risk10x Genomics Blog10x Genomics (TXG) Expands Capabilities with Proteintech Genomics Acquisition - GuruFocusFierceBiotechCeQur nabs $100M series E to fuel insulin patch commercialization10x Genomics News10x Genomics acquires Proteintech Genomics division - Investing.comPharmaVoiceWith a promising MASH asset, muscle-sparing GLP-1 and new CEO, Rivus gets ready to make its markPharmaVoiceWill obesity drugs save Pfizer from its post-COVID slump?10x Genomics Blog10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group - PR Newswire10x Genomics News10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group - TradingViewPromega BlogThe Molecular Blueprint for Virus-Resistant CowpeaFierceBiotechWith ADA in the books, analyst says Lilly is ‘widening its lead’ in the obesity raceFierceBiotechThe new standard for trusted AI in biopharmaEndpoints NewsPost-Hoc Live: How much is everyone in biopharma getting paid?
FierceBiotech Apr 25, 2026

Thermo Fisher sees higher Q1 earnings amid strong biopharma demand

Thermo Fisher sees higher Q1 earnings amid strong biopharma demand

Original
Body unavailable. Use the original source.